Clinical Trial Update: Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Liver Metastasis From Colon Cancer With Systemic Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating DEBIRI therapy combined with systemic FOLFOX/bevacizumab for liver metastases from colon cancer; study completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer with Liver Metastases

Drugs mentioned

• Bevacizumab (bevacizumab)
• Drug-eluting beads irinotecan (DEBIRI) (irinotecan-loaded drug-eluting beads)
• FOLFOX regimen (fluorouracil, oxaliplatin, leucovorin) (fluorouracil; oxaliplatin; leucovorin)

Snippet

Sponsor: University of Louisville | Conditions: Colon Cancer With Metastases to the Liver | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-05-07